NRAS and neoplasm: The primary tumor and lymph node lesions demonstrated the presence of NRAS G12C MT, although the MAF was close to the test’s cutoff value (primary average MAF: 5.0%, lymph node MAF: 1%) according to whole-exome tissue sequencing (Supplementary Table 1).